IL-7 fusion proteins
US7323549B2 · kind B2 · utility
23Cited by
69References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2004 |
| Grant date | Jan 29, 2008 |
| Priority date | — |
| Expiry date | Dec 30, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a fusion protein which includes a first portion including an immunoglobulin (Ig) chain and a second portion including interleukin-7 (IL-7).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.